HANS PETER HASLER Insider Trading $IDPH BIOGEN INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for HANS PETER HASLER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of HANS PETER HASLER. HANS PETER HASLER is Chief Operating Officer in BIOGEN INC. ($IDPH) and EVP, Global Neurology, Int'l in BIOGEN INC. ($IDPH) and SVP, International in BIOGEN INC. ($IDPH) and Director in Minerva Neurosciences, Inc. ($NERV) and Director in Patheon N.V. ($PTHN).
HANS PETER HASLER in BIOGEN INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of HANS PETER HASLER: Chief Operating Officer, EVP, Global Neurology, Int'l, SVP, International
Holdings: 53,261 shares
Latest Transaction: Feb 26 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of HANS PETER HASLER in BIOGEN INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, NERV, PTHN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Option Exercise | A | 49.65 | 53,565 | 2,659,502 | 53,565 | |
| Feb 26 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Grant | A | 0.00 | 20,140 | 0 | 53,261 | 33.1 K to 53.3 K (+60.81 %) |
| Feb 20 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Sell | S | 50.95 | 6,263 | 319,131 | 26,858 | 33.1 K to 26.9 K (-18.91 %) |
| Feb 20 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Sell | S | 50.93 | 5,430 | 276,542 | 33,121 | 38.6 K to 33.1 K (-14.09 %) |
| Feb 17 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Payment of Exercise | F | 52.61 | 350 | 18,414 | 44,814 | 45.2 K to 44.8 K (-0.77 %) |
| Feb 17 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Payment of Exercise | F | 52.61 | 404 | 21,254 | 45,164 | 45.6 K to 45.2 K (-0.89 %) |
| Feb 13 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Sell | S | 50.77 | 5,135 | 260,699 | 45,568 | 50.7 K to 45.6 K (-10.13 %) |
| Feb 10 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Option Exercise | M | 0.00 | 5,466 | 0 | 0 | |
| Feb 10 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Payment of Exercise | F | 52.48 | 331 | 17,371 | 50,703 | 51 K to 50.7 K (-0.65 %) |
| Feb 10 2009 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Buy | M | 0.00 | 5,466 | 0 | 51,034 | 45.6 K to 51 K (+12.00 %) |
| Nov 07 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Sell | S | 44.31 | 845 | 37,446 | 45,568 | 46.4 K to 45.6 K (-1.82 %) |
| Nov 04 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | Chief Operating Off ... | Payment of Exercise | F | 42.55 | 55 | 2,340 | 46,413 | 46.5 K to 46.4 K (-0.12 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Option Exercise | M | 49.31 | 12,950 | 638,565 | 38,850 | |
| Jul 24 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 69.31 | 12,950 | 897,565 | 46,468 | 59.4 K to 46.5 K (-21.79 %) |
| Jul 24 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Buy | M | 49.31 | 12,950 | 638,565 | 59,418 | 46.5 K to 59.4 K (+27.87 %) |
| Jun 03 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Option Exercise | A | 61.41 | 12,320 | 756,571 | 12,320 | |
| Jun 03 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Grant | A | 0.00 | 4,400 | 0 | 46,468 | 42.1 K to 46.5 K (+10.46 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.89 | 400 | 25,956 | 42,068 | 42.5 K to 42.1 K (-0.94 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.88 | 200 | 12,976 | 42,468 | 42.7 K to 42.5 K (-0.47 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.82 | 400 | 25,928 | 42,668 | 43.1 K to 42.7 K (-0.93 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.74 | 300 | 19,422 | 43,068 | 43.4 K to 43.1 K (-0.69 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.72 | 200 | 12,944 | 43,368 | 43.6 K to 43.4 K (-0.46 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.70 | 300 | 19,410 | 43,568 | 43.9 K to 43.6 K (-0.68 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.55 | 300 | 19,365 | 43,868 | 44.2 K to 43.9 K (-0.68 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.53 | 600 | 38,718 | 44,168 | 44.8 K to 44.2 K (-1.34 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.51 | 300 | 19,353 | 44,768 | 45.1 K to 44.8 K (-0.67 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.47 | 63 | 4,062 | 45,068 | 45.1 K to 45.1 K (-0.14 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.45 | 300 | 19,335 | 45,131 | 45.4 K to 45.1 K (-0.66 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.43 | 200 | 12,886 | 45,431 | 45.6 K to 45.4 K (-0.44 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.42 | 900 | 57,978 | 45,631 | 46.5 K to 45.6 K (-1.93 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.41 | 200 | 12,882 | 46,531 | 46.7 K to 46.5 K (-0.43 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.32 | 200 | 12,864 | 46,731 | 46.9 K to 46.7 K (-0.43 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.31 | 300 | 19,293 | 46,931 | 47.2 K to 46.9 K (-0.64 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.19 | 200 | 12,838 | 47,231 | 47.4 K to 47.2 K (-0.42 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.14 | 100 | 6,414 | 47,431 | 47.5 K to 47.4 K (-0.21 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.13 | 200 | 12,826 | 47,531 | 47.7 K to 47.5 K (-0.42 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.93 | 100 | 6,393 | 47,731 | 47.8 K to 47.7 K (-0.21 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.89 | 200 | 12,778 | 47,831 | 48 K to 47.8 K (-0.42 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.83 | 200 | 12,766 | 48,031 | 48.2 K to 48 K (-0.41 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.75 | 100 | 6,375 | 48,231 | 48.3 K to 48.2 K (-0.21 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.86 | 400 | 25,944 | 48,331 | 48.7 K to 48.3 K (-0.82 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.85 | 100 | 6,485 | 48,731 | 48.8 K to 48.7 K (-0.20 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.84 | 200 | 12,968 | 48,831 | 49 K to 48.8 K (-0.41 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.81 | 200 | 12,962 | 49,031 | 49.2 K to 49 K (-0.41 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.80 | 200 | 12,960 | 49,231 | 49.4 K to 49.2 K (-0.40 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.79 | 100 | 6,479 | 49,431 | 49.5 K to 49.4 K (-0.20 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.63 | 200 | 12,926 | 49,531 | 49.7 K to 49.5 K (-0.40 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Option Exercise | M | 43.50 | 6,869 | 298,802 | 0 | |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Option Exercise | M | 44.24 | 10,225 | 452,354 | 20,450 | |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.61 | 100 | 6,461 | 49,731 | 49.8 K to 49.7 K (-0.20 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.56 | 200 | 12,912 | 49,831 | 50 K to 49.8 K (-0.40 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.55 | 100 | 6,455 | 50,031 | 50.1 K to 50 K (-0.20 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.51 | 200 | 12,902 | 50,131 | 50.3 K to 50.1 K (-0.40 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.50 | 200 | 12,900 | 50,331 | 50.5 K to 50.3 K (-0.40 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.49 | 100 | 6,449 | 50,531 | 50.6 K to 50.5 K (-0.20 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.47 | 36 | 2,321 | 50,631 | 50.7 K to 50.6 K (-0.07 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.45 | 600 | 38,670 | 50,667 | 51.3 K to 50.7 K (-1.17 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.43 | 300 | 19,329 | 51,267 | 51.6 K to 51.3 K (-0.58 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.41 | 200 | 12,882 | 51,567 | 51.8 K to 51.6 K (-0.39 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.39 | 100 | 6,439 | 51,767 | 51.9 K to 51.8 K (-0.19 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.38 | 200 | 12,876 | 51,867 | 52.1 K to 51.9 K (-0.38 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.32 | 400 | 25,728 | 52,067 | 52.5 K to 52.1 K (-0.76 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.31 | 200 | 12,862 | 52,467 | 52.7 K to 52.5 K (-0.38 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.14 | 100 | 6,414 | 52,667 | 52.8 K to 52.7 K (-0.19 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.13 | 200 | 12,826 | 52,767 | 53 K to 52.8 K (-0.38 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.93 | 100 | 6,393 | 52,967 | 53.1 K to 53 K (-0.19 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.89 | 300 | 19,167 | 53,067 | 53.4 K to 53.1 K (-0.56 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.80 | 77 | 4,913 | 53,367 | 53.4 K to 53.4 K (-0.14 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.76 | 23 | 1,466 | 53,444 | 53.5 K to 53.4 K (-0.04 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.93 | 2,300 | 147,039 | 53,467 | 55.8 K to 53.5 K (-4.12 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.90 | 100 | 6,390 | 55,767 | 55.9 K to 55.8 K (-0.18 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.89 | 600 | 38,334 | 55,867 | 56.5 K to 55.9 K (-1.06 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.88 | 2,084 | 133,126 | 56,467 | 58.6 K to 56.5 K (-3.56 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.87 | 1,385 | 88,460 | 58,551 | 59.9 K to 58.6 K (-2.31 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.85 | 300 | 19,155 | 59,936 | 60.2 K to 59.9 K (-0.50 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 63.83 | 100 | 6,383 | 60,236 | 60.3 K to 60.2 K (-0.17 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Buy | M | 43.50 | 6,869 | 298,802 | 60,336 | 53.5 K to 60.3 K (+12.85 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Sell | S | 64.24 | 10,225 | 656,854 | 53,467 | 63.7 K to 53.5 K (-16.05 %) |
| Apr 10 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Buy | M | 44.24 | 10,225 | 452,354 | 63,692 | 53.5 K to 63.7 K (+19.12 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Option Exercise | A | 60.56 | 48,570 | 2,941,399 | 48,570 | |
| Feb 14 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Grant | A | 0.00 | 17,340 | 0 | 53,467 | 36.1 K to 53.5 K (+48.00 %) |
| Feb 14 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Payment of Exercise | F | 60.56 | 404 | 24,466 | 36,127 | 36.5 K to 36.1 K (-1.11 %) |
| Feb 07 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Option Exercise | M | 0.00 | 5,467 | 0 | 5,466 | |
| Feb 07 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Payment of Exercise | F | 60.52 | 331 | 20,032 | 36,531 | 36.9 K to 36.5 K (-0.90 %) |
| Feb 07 2008 | IDPH | BIOGEN INC. | HASLER HANS PETER | EVP, Global Neurolo ... | Buy | M | 0.00 | 5,467 | 0 | 36,862 | 31.4 K to 36.9 K (+17.41 %) |
| Nov 02 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | A | 72.87 | 6,900 | 502,803 | 6,900 | |
| Nov 02 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Grant | A | 0.00 | 2,700 | 0 | 31,395 | 28.7 K to 31.4 K (+9.41 %) |
| Oct 17 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | M | 49.49 | 86,250 | 4,268,513 | 0 | |
| Oct 17 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | M | 67.57 | 22,500 | 1,520,325 | 22,500 | |
| Oct 17 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Sell | S | 82.00 | 108,750 | 8,917,500 | 28,695 | 137.4 K to 28.7 K (-79.12 %) |
| Oct 17 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Buy | M | 67.57 | 22,500 | 1,520,325 | 137,445 | 114.9 K to 137.4 K (+19.57 %) |
| Oct 17 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Buy | M | 49.49 | 86,250 | 4,268,513 | 114,945 | 28.7 K to 114.9 K (+300.58 %) |
| Aug 31 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | M | 44.24 | 10,225 | 452,354 | 30,675 | |
| Aug 31 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Sell | S | 64.24 | 10,225 | 656,854 | 28,695 | 38.9 K to 28.7 K (-26.27 %) |
| Aug 31 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Buy | M | 44.24 | 10,225 | 452,354 | 38,920 | 28.7 K to 38.9 K (+35.63 %) |
| Aug 29 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | M | 43.50 | 20,606 | 896,361 | 6,869 | |
| Aug 29 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Sell | S | 63.50 | 20,606 | 1,308,481 | 28,695 | 49.3 K to 28.7 K (-41.80 %) |
| Aug 29 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Buy | M | 43.50 | 20,606 | 896,361 | 49,301 | 28.7 K to 49.3 K (+71.81 %) |
| Jul 27 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | M | 37.45 | 34,500 | 1,292,025 | 0 | |
| Jul 27 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Sell | S | 57.45 | 34,500 | 1,982,025 | 28,695 | 63.2 K to 28.7 K (-54.59 %) |
| Jul 27 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Buy | M | 37.45 | 34,500 | 1,292,025 | 63,195 | 28.7 K to 63.2 K (+120.23 %) |
| Mar 22 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Sell | S | 44.48 | 5,910 | 262,870 | 28,695 | 34.6 K to 28.7 K (-17.08 %) |
| Mar 16 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Payment of Exercise | F | 44.11 | 315 | 13,895 | 34,605 | 34.9 K to 34.6 K (-0.90 %) |
| Mar 16 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Grant | A | 0.00 | 6,225 | 0 | 34,920 | 28.7 K to 34.9 K (+21.69 %) |
| Feb 15 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Sell | S | 49.22 | 5,190 | 255,431 | 28,695 | 33.9 K to 28.7 K (-15.32 %) |
| Feb 14 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | A | 49.31 | 51,800 | 2,554,258 | 51,800 | |
| Feb 14 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Grant | A | 0.00 | 20,000 | 0 | 33,885 | 13.9 K to 33.9 K (+144.04 %) |
| Feb 08 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Option Exercise | D | 0.00 | 5,467 | 0 | 10,933 | |
| Feb 08 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Payment of Exercise | F | 48.94 | 740 | 36,216 | 13,885 | 14.6 K to 13.9 K (-5.06 %) |
| Feb 08 2007 | IDPH | BIOGEN INC. | HASLER HANS PETER | SVP, International | Buy | M | 0.00 | 5,467 | 0 | 14,625 | 9.2 K to 14.6 K (+59.70 %) |
Page: 1